Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 7/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.38 |
| ▸ | PDE2A | O00408 | 1/20 | 0.36 |
| ▸ | PDE1A | P54750 | 1/20 | 0.36 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.36 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.33 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.33 |
| ▸ | SIRT5 | Q9NXA8 | 3/20 | 0.33 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6996703 | 0.88 | SIRT1 (0.46) | ADORA2BADORA2APDE2APDE1APDE1B | |
| SCHEMBL7661316 | 0.82 | ADORA2A (0.41) | ADORA2BADORA2AADORA1ADORA3SIRT1 | |
| SCHEMBL8562832 | 0.81 | ADORA2B (0.43) | ADORA2BADORA2APDE2APDE1APDE1B | |
| SCHEMBL7667529 | 0.78 | ADORA2A (0.38) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL7670431 | 0.71 | ADORA2B (0.54) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL7667724 | 0.71 | RXFP1 (0.35) | ADORA2AADORA1 | |
| SCHEMBL7668320 | 0.71 | ADORA1 (0.53) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL7659412 | 0.70 | ADORA2B (0.45) | ADORA2BADORA2AADORA1ADORA3SIRT1 | |
| SCHEMBL7671642 | 0.69 | ADORA2A (0.42) | ADORA2BADORA2AADORA1ADORA3 | |
| SCHEMBL7666406 | 0.68 | ADORA3 (0.51) | ADORA2BADORA2AADORA1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1087973-B1 | IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY | BOEHRINGER INGELHEIM PHARMA (DE) | 2003-01-08 | — | — | EP | claimed |
| EP-1087973-A1 | IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY | Boehringer Ingelheim Pharma KG (DE) | 2001-04-04 | — | — | EP | claimed |
| WO-1999065912-A1 | IMIDAZOTRIAZOLOPYRIMIDINES USED AS A DRUG HAVING AN ADENOSINE ANTAGONIST ACTIVITY | BOEHRINGER INGELHEIM PHARMA KG (DE) | 1999-12-23 | — | — | WO | claimed |
| US-6492377-B1 | Imidazotriazolopyrimidines with adenosine-antagonistic activity | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-12-10 | — | — | US | disclosed |